|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 160.10 EUR | -2.73% |
|
-10.96% | -23.81% |
| 07:38am | RBC Sees Sartorius Stedim Biotech Share Weakness as 'Entry Point'; Rating, Price Target Revised | MT |
| Mar. 06 | RBC Capital Upgrades Sartorius Stedim Biotech to Outperform Rating, Reduces PT | MT |
| Capitalization | 16.01B 18.57B 14.46B 13.87B 25.3B 1,707B 26.47B 171B 68.47B 819B 69.71B 68.23B 2,928B | P/E ratio 2026 * |
38.9x | P/E ratio 2027 * | 30.2x |
|---|---|---|---|---|---|
| Enterprise value | 18.04B 20.93B 16.29B 15.63B 28.5B 1,923B 29.83B 193B 77.14B 922B 78.54B 76.87B 3,298B | EV / Sales 2026 * |
5.66x | EV / Sales 2027 * | 5.01x |
| Free-Float |
30.28% | Yield 2026 * |
0.54% | Yield 2027 * | 0.7% |
Last Transcript: Sartorius Stedim Biotech
| 1 day | -3.31% | ||
| 1 week | -11.44% | ||
| Current month | -13.08% | ||
| 1 month | -10.72% | ||
| 3 months | -23.52% | ||
| 6 months | -9.21% | ||
| Current year | -24.21% |
| 1 week | 158.15 |  | 177.75 |
| 1 month | 158.15 | | 185 |
| Current year | 158.15 | | 224 |
| 1 year | 148.75 | | 224 |
| 3 years | 139.1 | | 311.3 |
| 5 years | 139.1 | | 551 |
| 10 years | 50.1 | | 551 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 50 | 2023-03-27 |
| Chief Tech/Sci/R&D Officer | 61 | 2011-09-07 | |
Petra Kirchhoff
IRC | Investor Relations Contact | 57 | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 64 | 2015-04-06 | |
Susan Dexter
BRD | Director/Board Member | 69 | 2015-04-06 |
Lothar Kappich
BRD | Director/Board Member | 69 | 2017-09-13 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -4.06% | 0.42% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.25% | -11.44% | -15.46% | -48.76% | 18.57B | |
| -1.33% | -5.84% | -20.11% | +10.22% | 190B | |
| -2.27% | -6.92% | -3.81% | +15.94% | 117B | |
| -0.23% | -3.68% | +40.80% | +136.05% | 69.73B | |
| -6.12% | -4.84% | +53.87% | +87.56% | 60.92B | |
| -1.66% | -5.30% | -27.19% | -28.95% | 47.59B | |
| -0.50% | -7.75% | - | - | 35.57B | |
| -3.66% | -7.26% | -12.51% | -39.60% | 26.21B | |
| -3.35% | -8.65% | -0.96% | +27.86% | 22.61B | |
| -0.92% | +0.20% | -24.44% | +11.86% | 19.29B | |
| Average | -2.06% | -5.69% | -1.09% | +19.13% | 60.76B | |
| Weighted average by Cap. | -1.50% | -5.38% | -0.96% | +28.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.19B 3.69B 2.88B 2.76B 5.03B 340B 5.27B 34B 13.62B 163B 13.87B 13.57B 582B | 3.55B 4.11B 3.2B 3.07B 5.6B 378B 5.86B 37.83B 15.16B 181B 15.43B 15.1B 648B |
| Net income | 411M 477M 371M 356M 649M 43.82B 680M 4.39B 1.76B 21.01B 1.79B 1.75B 75.15B | 517M 599M 466M 447M 816M 55.06B 854M 5.51B 2.21B 26.4B 2.25B 2.2B 94.43B |
| Net Debt | 2.03B 2.35B 1.83B 1.76B 3.2B 216B 3.35B 21.64B 8.67B 104B 8.83B 8.64B 371B | 1.73B 2.01B 1.56B 1.5B 2.73B 184B 2.86B 18.46B 7.4B 88.43B 7.53B 7.37B 316B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-03-09 | 160.10 € | -2.73% | 25,330 |
| 26-03-06 | 164.60 € | -3.26% | 100,825 |
| 26-03-05 | 170.15 € | -2.63% | 73,504 |
| 26-03-04 | 174.75 € | +4.61% | 81,428 |
| 26-03-03 | 167.05 € | -7.04% | 141,055 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DIM Stock
Select your edition
All financial news and data tailored to specific country editions
